Figure 3 shows the results of the presence of the selected mutations in the CTCs together with the CNA data derived from the low-pass analysis. Since the primary and recurrent tumor tissues showed BRAF V600E mutation, we examined the presence of BRAF V600E in CTCs. All CTCs were wild type for BRAF V600E. The gene discussed is BRAF; the disease is neoplasm.